4D Molecular Therapeutics Inc (NASDAQ: FDMT) Stock Could Reward Investors With A Loss Of -907.56%
In the last trading session, 1.0 million shares of the 4D Molecular Therapeutics Inc (NASDAQ:FDMT) were traded, and its beta was 2.82. Most recently the